Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
To determine suitability, a full clinical assessment is required through the free online consultation
Beyond cost management, offering structured access to GLP-1 therapies strengthens workforce stability
Early data from the TRIUMPH trials is undeniably compelling, showing unprecedented weight loss of up to 28.7% at 68 weeks significantly outpacing tirzepatide in early comparisons (see our Retatrutide vs Tirzepatide comparison guide)
Table 61: Comparators included in the network meta-analysis vvvvvvv vvvvvvvvvv vvvvvvvvvvv vvvvvvvvvv vvvvv vvv vvvvvvvvvvvvv vvvvvvv vvvvvvvv vvvvvvvv vvvvvvvv vvvvvvvvvvvvvvvvvvvvvvvvvvvvvvv vvvvvvvvvv vvv vvvvvvvvvvvvv vvvv vvvvvvvvvvvvvvvvvv Analysis: The submitted ITC used a Bayesian-based framework to conduct multiple network meta-analyses
US$ 21.55
US$ 22.22
?unique=16ad55f)
US$ 28.63
US$ 22.27
US$ 29.37
US$ 24.54
US$ 24.15
